Director sold
~$44KReported value · 275 sh @ $161.00
A board member of Repligen sold $44K of Repligen shares. Nobody planned it ahead of time.
Loading…
Traded Nov 25, 2025 · Filed Nov 27, 2025
The boss of Repligen sold $1.2M of Repligen shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,196,970
Shares × reported transaction price
28 days after results of Oct 28, 2025, 91 days before results of Feb 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.5% | +0.3% | −3.9% |
| 30 days | −3.1% | +0.7% | −3.7% |
| 90 days | −21.9% | +0.9% | −22.7% |
| 180 days | −33.8% | +9.8% | −43.6% |
Past results only. Not a forecast.
A board member of Repligen sold $44K of Repligen shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.